Join us in our mission to support and Empowering Communities Together
New England Korean Society of Medicine!
Join us in our mission to support and Empowering Communities Together
Who We Are
Our Vision
NEKSOM is dedicated to creating a collaborative platform for physicians of Korean heritage in New England to connect, share knowledge, and grow together. Our members encompass patient care, education, research, health care industry, and policy-making. Through symposiums, small group meetings, and networking events, we provide opportunities for professional development, mutual learning, and the exchange of valuable insights. By fostering a supportive community, we aim to enhance medical practice, elevate healthcare outcomes, and contribute to the growth of our members and the broader medical community.
Hope for Neksom Community
Annual Symposium
Theme: Empowering MD/PhD Scientists and Innovators
Date/Time: Thursday, September 26, 2024, at 5:00-8:30 PM
Place: CIC, Cambridge
The New England Korean Society of Medicine (NEKSOM) hosted its Annual Symposium, aimed at fostering collaboration, mentorship, and knowledge sharing among professionals in the medical community. The event brought together experts to discuss innovation in medicine, scientific research, and career development, and was supported by the Boston Consulate General of the Republic of Korea and the Korea Health Industry Development Institute (KHIDI).
Symposium Agenda
5:00-5:40PM Reception and Dinner
5:40-6:00 Opening Remarks
Consulate General of the Republic of Korea in Boston Consul General Jaehui Kim
Director of KHIDI Boston, Soonman Park
President of New England Korean Society of Medicine (NEKSOM) Professor Young H Kim, MD, PhD
Key Note Presentation (Moderator Dr Jiwon Kim, Seoul National University)
6:00 – 6:40 PM Overcoming Immune Cell Exhaustion in GBM
Dr Mark Lim, MD, Professor, Chairman of Neurosurgery Stanford University
Session 1 Cutting Edge Research in Cardiology and Transplantation Surgery
6:40-6:55 PM Robotic Innovation in Liver Transplant: Living Donor Hepatectomy
6:55-7:00 PM Q&A
Dr Seungduk Lee, MD, PhD, Transplantation Surgery, VCU Health
7:00-7:20 PM Break & Group Photo
Session 2 Empowering Innovation: Advancing MD/PhD Scientists in Research
Panel 1 Pursuing Path of Physician Scientist
7:20-7:30PM Introduction of MD/PhD Scientist
Professor Chungeun Lee, MD, PhD, Brown University
7:30 – 8:00PM Panel Discussion (Moderator Professor Chungeun Lee)
Panelists: Minsun Kim, MD, PhD student, Harvard University; Daniel Kim, MD-PhD student, Harvard/MIT; Chanmi Lee, MD hD, Heme/Onc Fellow, BIDMC; Changhyeon Ryu, MD PhD, Postdoctoral Fellow, MIT
Panel 2 Integrating Clinical Practice and Research
8:00-8:30 PM, Panel Discussion (Moderator Dr Jong Chul Park)
Panelists: Drs from MGH. Hanna Gaggin, Albert Kim, Richard Lee
8:30PM Closing Professor Young H Kim
Special Lecture: Meet the CEO
Title: MD to CEO
Speaker: Dr. Dongsoo Lee, MD, PhD, MBA
Date/Time: Thursday, October 24, 2024, at 6:00 PM
Place: Longfellow's Wayside Inn, Sudbury
Dr. Dongsoo Lee shared his inspiring journey from a practicing physician to a leader in the biomedical industry. Emphasizing his transformation, he highlighted how his medical background served as a core foundation for his achievements in the industry. Dr. Lee discussed his accomplishments and the challenges he faced, illustrating how being an MD was integral to his mission of becoming a leader and innovator in the biomedical field.
Upcoming Event: Special Lecture for the Korean American Seniors Association of Boston
Theme: Regular check-ups and early diagnosis are crucial. Diabetic retinopathy and age-related macular degeneration.
Speakers: Dr Yoon Jeon Kim, MD, PhD.
Date/Time: Wednesday, November 6, 2024, at 11:00AM
Place: 57 Peters Street, North Andover
Dr. Yoonjeon Kim, Associate Professor at Asan Medical Center and visiting professor at Harvard Medical School, will discuss the importance of regular eye check-ups and early diagnosis in preventing vision loss from common retinal conditions. This lecture is part of our Community Outreach Program and is open to members of the Korean American Seniors Association of Boston (보스톤 한미 노인회).
Upcoming Event: New Year Gathering
Theme: A Fulfilling Life in Medicine: Balancing Career, Life, and Family
Speakers: Dr Hanna Gaggin, Dr Richard Lee, Dr Albert Kim, Dr Jong Chul Park
Date/Time: Friday, January 31, 2025
Place: TBA
Event Registration:
Registration for the New Year Gathering will open on January 3, 2025. Don’t miss this opportunity to join us for an evening of mentorship, growth, and discussions on work-life balance.
Esteemed doctors from MGH will share their insights and experiences on maintaining success in their careers, balancing life and family, and achieving work-life harmony. This discussion is designed to inspire and guide trainees and young doctors as they navigate their own professional and personal journeys.
Upcoming Event: Special Lecture: Meet the CEO
Theme: Discovery and Development of Lazertnib, an USFDA approved Lung Cancer Drug
Speakers: Dr Ko, Jong Sung, PhD
Date/Time: Thursday, March 13, 2025
Place: TBA
Event Registration:
Registration for the special lecture will open on February, 2025. Don’t miss this opportunity to join us for an evening of insight into the process of drug development from scratch. We will explore the stages involved, challenges faced, and the journey from initial research to successful FDA approval.
This event is open to members of NEKSOM and invited guests only.
Dr. Ko, Jong Sung played a pivotal role in the discovery and development of lazertinib, a lung cancer drug approved by the USFDA. Lazertinib is used primarily for treating non-small cell lung cancer (NSCLC) with EGFR mutations. Dr. Ko's contributions are significant in the field of oncology, particularly in developing targeted therapies that improve progression-free survival rates and overall survival for patients. His work has been instrumental in advancing treatments for lung cancer, offering new hope for improved patient outcomes
Dr. Ko Jong Sung is a prominent scientist known for his leadership in drug discovery, particularly in the development of lazertinib, an FDA-approved lung cancer drug. He currently serves as the President and Chief Executive Officer at Genosco, a biotechnology company. Dr. Ko has an extensive background in scientific research and management, . He was also a Visiting Scientist at UC Berkeley.
Dr. Ko holds a Ph.D. in Bioorganic Chemistry from Caltech and has a strong focus on anti-cancer research. His work in developing targeted therapies like lazertinib is recognized for advancing treatments for non-small cell lung cancer (NSCLC), especially for patients with specific genetic mutations.
Upcoming Events
If you have any questions about our organization or want to learn more about how you can get involved, please don't hesitate to contact us. We are always happy to hear from members of our community.
NEKSOM Alumni Network
Alumni Events & Reunions
Alumni Events & Reunions
Alumni Events & Reunions
Mentorship Opportunities
Alumni Events & Reunions
Alumni Events & Reunions
Stay Connected
Alumni Events & Reunions
Alumni Highlights